Neurones's ROE % for the quarter that ended in Dec. 2025 was 15.24%. Neurones's PB Ratio for the quarter that ended in Dec. 2025 was 2.62.
Neurones's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 5.82%.
Neurones ROE % Adjusted to Book Value Related Terms
Neurones ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Neurones's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: ROE % Adjusted to Book Value Comparison
For the Information Technology Services subindustry, Neurones's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones ROE % Adjusted to Book Value vs Software Industry
For the Software industry and Technology sector, Neurones's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Neurones's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 5.82% mean?
Neurones (XPAR:NRO) has a ROE % Adjusted to Book Value of 5.82% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neurones and its competitors.
Is Neurones' ROE % Adjusted to Book Value too high?
Neurones' current ROE % Adjusted to Book Value is 5.82%. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' ROE % Adjusted to Book Value compare to IBM and ACN?
Neurones' ROE % Adjusted to Book Value of 5.82% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Software company?
A good ROE % Adjusted to Book Value depends on the Software industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neurones and its competitors. Neurones's current ROE % Adjusted to Book Value is 5.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.27, compared to a current price of €34.55 — trading 31.3% below its estimated fair value. The current ROE % Adjusted to Book Value is 5.82%. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current ROE % Adjusted to Book Value is 5.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €34.55 is trading 31.3% below its estimated GF Value™ of €50.27.
GuruFocus considers Neurones to be Significantly Undervalued.
Key valuation signals for XPAR:NRO:
ROE % Adjusted to Book Value: 5.82%
GF Value™: €50.27 vs. price of €34.55 (31.3% below fair value)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
96GF Score
Get the complete analysis for XPAR:NRO
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
